Page 5 - Pharmaceutical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?

SWK (NASDAQ:SWKH – Get Free Report) and TROOPS (NASDAQ:TROO – Get Free Report) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings. Analyst Recommendations This is a breakdown of recent ratings and […]

SWK (NASDAQ:SWKH – Get Free Report) and TROOPS (NASDAQ:TROO – Get Free Report) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability. Institutional & Insider Ownership 99.3% of SWK shares are held […]

Pratteln, Switzerland, December 7, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer (CCO) and of Marc Schrader to Chief Technology Officer (CTO). Both will join the six-member Executive Committee effective January 1, 2024. “Santhera is transitioning to the commercial phase and will make AGAMREE® (vamorolone) available to patients in Europe starting in Germany in early 2024, subject to approval by the European Commissi

Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET Corporate Highlights Third quarter of 2023 GAAP net income...